Proxy Votes Now

Home › Funds › PRIMECAP Odyssey Growth Fund

PRIMECAP Odyssey Growth Fund (POGRX) proxy voting record 2025-2026

Fund family: PRIMECAP Odyssey Funds · Filed by PRIMECAP Odyssey Funds (CIK 1293967) · SEC series S000005540

Ticker: POGRX (C000015070)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,118 with, 133 against, 4 abstentions (not counted as with management); 38 items carried no recommendation. Shareholder proposals: 9 FOR, 125 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other PRIMECAP Odyssey Funds funds is possible: fewer than three other funds of the family voted in 2025-2026.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 85.6% of this fund’s 2,255 such votes could be given a sector; the other 324 (14.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary535346.4%
Technology533539.9%
Health Care271124.4%
Industrials264134.9%
Finance176137.4%
Energy10265.9%
Consumer Staples2414.2%
Basic Materials1516.7%
Real Estate1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,5232
Audit-related1850
Say-on-Pay1761
Corporate Governance16151
Capital Structure831
Compensation633
Other Social Issues2623
Other254
Human Rights or Human Capital/workforce2020
Environment or Climate1616

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
MICRON TECHNOLOGY, INC.January 15, 2026$838M121
XOMETRY, INC.June 16, 2026$437M50
ELI LILLY AND COMPANYMay 4, 2026$351M102
INTEL CORPORATIONMay 13, 2026$166M183
BIOGEN INC.June 9, 2026$155M120
ALPHABET INC.June 5, 2026$134M2310
MICROSOFT CORPORATIONDecember 5, 2025$127M216
RHYTHM PHARMACEUTICALS, INC.June 24, 2026$118M40

Notable votes against management

MeetingCompanyProposalFundMgmt
January 15, 2026MICRON TECHNOLOGY, INC.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalAgainstFor
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 13, 2026INTEL CORPORATIONStockholder proposal requesting a report on risk of China exposure. Shareholder proposalAgainstFor
May 13, 2026INTEL CORPORATIONStockholder proposal requesting a report on Intel's human rights due diligence process. Shareholder proposalAgainstFor
June 5, 2026ALPHABET INC.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026ALPHABET INC.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
December 5, 2025MICROSOFT CORPORATIONEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025MICROSOFT CORPORATIONReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 24, 2026NVIDIA CORPORATIONApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CORPORATIONApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 19, 2026AMGEN INC.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor

Search this fund’s votes by company

2,302 ballot items at 181 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, PRIMECAP Odyssey Growth Fund (POGRX) voted at 181 shareholder meetings of 176 companies, on 2,302 ballot items in all. Where management made a recommendation, the fund followed it on 93.9% of the items and voted against it 133 times. Its most frequent area of disagreement was corporate governance (51 of its votes against management). It voted FOR 6.7% of the 134 shareholder proposals on which it cast a FOR or AGAINST vote.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.